Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock portfolio company news Jul 27 Written by MacDougall Creative MacDougall Creative https://www.macbiocom.com Previous Previous MindMed Secures $50.0 Million Credit Facility with K2 HealthVentures Next Next VBI Vaccines Announces Pricing of $18 Million Public Offering and $3 Million Concurrent Registered Direct Offering
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock portfolio company news Jul 27 Written by MacDougall Creative MacDougall Creative https://www.macbiocom.com
